Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 89.50
+1.60 (1.82%)
Jun 12, 2026, 5:00 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 495.14 million as of June 12, 2026. Its market cap has decreased by -10.86% in one year.
Market Cap
495.14M
Enterprise Value
434.34M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
89.50
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 495.14M, an increase of 330.41%. That is a compound annual growth rate of 37.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 495.14M | 29.57% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 489.21M |
| Ryvu Therapeutics | 356.05M |
| BIOTON | 343.46M |
| Syn2bio | 285.01M |
| Synthaverse | 206.10M |
| Mabion | 116.37M |
| Molecure | 112.91M |
| Poltreg | 111.23M |